Fellowships, Grants, and Awards
For more information on job openings in the environmental health sciences, see EHP's Career Opportunities page. For more information on employment and training at the NIEHS, see http://www.niehs.nih.gov/external/emptrain.htm. Complete information on NIH funding opportunities and notices is available at http://grants.nih.gov/grants/guide/index.html.
For advertisers only: If you would like to publish a Fellowship, Grant, or Award announcement in EHP, please e-mail Erin Dooley at dooley@niehs.nih.gov.
Climate Change and Allergic Airway Disease
The Environmental Protection Agency Office of Research and Development, National Center for Environmental Research, in cooperation with the EPA Global Change Research Program, announces an extramural funding competition supporting research on the impact of global change on the burden of allergic airway disease from exposure to pollen, mold, and other plant-derived allergens. Under the Global Change Research Act of 1990, the United States Climate Change Science Program is required to undertake scientific assessments of the potential consequences of global change for the United States (e.g. Patz et al., 2000). Global changes encompass changes in climate, climate variability, land-use, economic development, population dynamics, and technology advances. EPA is interested in supporting research on the analysis of health outcomes that may be affected by future global changes and fostering a better understanding of the consequences of global change for human health. The complete version of this announcement is available at http://es.epa.gov/ncer/rfa/2008/2008_star_climate_change.html
Exploratory Collaborations with National Centers for Biomedical Computing (R21)
This funding opportunity announcement is for projects from individual-investigators or small groups to collaborate with the NIH Roadmap for Medical Research National Centers for Biomedical Computing (NCBCs). For a description of the NCBCs see http://www.bisti.nih.gov/ncbc/. The intention of the collaborating projects is to engage researchers across the nation in building an excellent biomedical computing environment, using the computational tools and biological and behavioral application drivers of the funded NCBCs as foundation stones. This FOA is intended to support exploratory biomedical informatics and computational biology research—applications should be innovative, with high risk/high impact in new areas that are lacking preliminary data or development. Applications for R21 awards should describe projects distinct from those supported through the traditional R01 mechanism. For example, long-term projects, or projects designed to increase knowledge in a well-established area will not be considered for R21 awards. The complete version of this announcement is available at http://grants.nih.gov/grants/guide/pa-files/PAR-08-183.html
Collaborations with National Centers for Biomedical Computing (R01)
This funding opportunity announcement is for projects from individual-investigators or small groups to collaborate with the NIH Roadmap for Medical Research National Centers for Biomedical Computing (NCBCs). For a description of the NCBCs see http://www.bisti.nih.gov/ncbc/. The intention of the collaborating projects is to engage researchers across the nation in building an excellent biomedical computing environment, using the computational tools and biological and behavioral application drivers of the funded NCBCs as foundation stones. The complete version of this announcement is available at http://grants.nih.gov/grants/guide/pa-files/PAR-08-184.html
Outstanding New Environmental Scientist Award (ONES) (R01)
The Outstanding New Environmental Scientist Award is intended to identify outstanding scientists who are in the early, formative stages of their careers and who intend to make a long term career commitment to research in the mission areas of the NIEHS and assist them in launching an innovative research program focusing on problems of environmental exposures and human biology, human pathophysiology and human disease. The complete version of this announcement is available at http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-08-003.html
Clinical Centers for the NHLBI Asthma Network (AsthmaNet) (U10)
The purpose of this funding opportunity announcement (FOA), issued by NHLBI, NIH, is to invite applications to participate in the NHLBI Asthma Network (AsthmaNet), a clinical research network that will develop and conduct multiple clinical trials to address the most important asthma management questions and new treatment approaches in pediatric and adult populations. AsthmaNet is designed to promote cooperation and coordination, facilitate scientific exchange, provide training opportunities, and leverage resources. AsthmaNet will include multiple Clinical Centers and one Data Coordinating Center. The protocols will include clinical trials to evaluate and/or compare existing or new therapeutic approaches to asthma management as well as a limited number of proof-of-concept studies to advance the development of novel therapies and studies that investigate the mechanistic bases for interventions examined in AsthmaNet. The complete version of this announcement is available at http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-08-010.html
Data Coordinating Center for the NHLBI Asthma Network (AsthmaNet) (U10)
The purpose of this funding opportunity is to invite applications to participate as Data Coordinating Center in the NHLBI Asthma Network (AsthmaNet), a clinical research network that will develop and conduct multiple clinical trials to address the most important asthma management questions and new treatment approaches in pediatric and adult populations. AsthmaNet is designed to promote cooperation and coordination, facilitate scientific exchange, provide training opportunities, and leverage resources. AsthmaNet will include multiple Clinical Centers and one Data Coordinating Center. The protocols will include clinical trials to evaluate and/or compare existing or new therapeutic approaches to asthma management as well as a limited number of proof of concept studies to advance the development of novel therapies and studies that investigate the mechanistic bases for interventions examined in AsthmaNet. The complete version of this announcement is available at http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-08-011.html
Millennium Promise Awards: Non-communicable Chronic Diseases Research Training Program (NCoD) (D43)
This research training program is designed to build research capacity in low- and middle-income countries (LMICs) in the fields related to cancer, cerebrovascular disease including stroke, lung disease including chronic obstructive pulmonary disease (COPD) and environmental factors including indoor air pollution, and obesity and lifestyle factors related to these conditions as well as genetics of non-communicable diseases. The institutions applying can be domestic or foreign, but have to exhibit the ability to do such training, and must exhibit that they have existing research programs in these fields. The complete version of this announcement is available at: http://grants.nih.gov/grants/guide/pa-files/PAR-08-175.html
National Center on Minority Health and Health Disparities Comprehensive Centers of Excellence (P60)
This FOA issued by the National Center on Minority Health and Health Disparities (NCMHD), National Institutes of Health solicits grant applications from institutions/organizations that propose to establish an Comprehensive NCMHD Center of Excellence (COE) contributing to either the improvement of minority health, the elimination of health disparities, or both. To be eligible for the COE in this FOA, applicant institutions must have existing federal research support and/or research infrastructure as reflected in a level of NIH institutional funding of more than or equal to $80 million for the year 2007. An Comprehensive NCMHD COE supported under this FOA must contain an Administrative core, a Research core, a Research Training/Education core, and a Community/Engagement core. Pilot research projects or feasibility projects/studies are not supported under this FOA. The complete version of this announcement is available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-08-005.html
National Center on Minority Health and Health Disparities Exploratory Centers of Excellence (R20)
This FOA issued by the National Center on Minority Health and Health Disparities (NCMHD), National Institutes of Health solicits grant applications from institutions/organizations that propose to establish an Exploratory NCMHD Center of Excellence (COE) contributing to either the improvement of minority health, the elimination of health disparities, or both. To be eligible for the COE in this FOA, applicant institutions must have existing federal research support and/or research infrastructure as reflected in a level of NIH institutional funding of less than $80 million for the year 2007. An Exploratory NCMHD COE supported under this FOA must contain an Administrative core, a Research core, a Research Training/Education core, and a Community/Engagement core. Pilot research projects or feasibility projects/studies are not supported under this FOA. The complete version of this RFA is available at http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-08-004.html
Innovative and Integrative Approaches for Advancing Public Health Protection Through Water Infrastructure Sustainability
The U.S. Environmental Protection Agency (EPA), as part of its Science to Achieve Results (STAR) program, is seeking applications to develop advanced concepts for linking public health protection with water infrastructure sustainability. Innovative and integrative approaches are sought for monitoring, modeling, operation, and management of drinking water distribution and storage systems and wastewater collection systems that can lead to improved water quality and reduced health risks. The complete version of this announcement is available at: http://es.epa.gov/ncer/rfa/2008/2008_star_water.html
Functional Characterization of Genetic Variants and Interactions: The Genes, Environment and Health Initiative (R21)
The National Institute on Drug Abuse on behalf of the NIH Genes, Environment and Health Initiative encourages functional characterization of genetic variants that have been statistically nominated to be associated with a particular outcome through common, complex disease gene discovery approaches, such as genome-wide association studies, candidate gene approaches, or sequencing studies. This FOA supports research relating genetic variation to biological mechanism, or disease causality. Areas of interest include, but are not limited to, relatively low throughput approaches (e.g. transgenic mouse approaches) to test some of the most promising variants for changes in function; or exploit high-throughput tests (e.g. yeast, C. elegans, cell culture systems, or computational approaches) to look at different aspects of variant function.The complete version of this RFA is available at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-003.html
Functional Characterization of Genetic Variants and Interactions: The Genes, Environment and Health Initiative (R03)
The National Institute on Drug Abuse on behalf of the NIH Genes, Environment and Health Initiative encourages functional characterization of genetic variants that have been statistically nominated to be associated with a particular outcome through common, complex disease gene discovery approaches, such as genome-wide association studies, candidate gene approaches, or sequencing studies. This FOA supports research relating genetic variation to biological mechanism, or disease causality. Areas of interest include, but are not limited to, relatively low throughput approaches (e.g. transgenic mouse approaches) to test some of the most promising variants for changes in function; or exploit high-throughput tests (e.g. yeast, C. elegans, cell culture systems, or computational approaches) to look at different aspects of variant function. The complete version of this RFA is available at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-09-004.html
NIH Support for Conferences and Scientific Meetings (Parent R13/U13)
The purpose of the NIH Research Conference Grant Program (R13 and U13) is to support high quality conferences/scientific meetings that are relevant to the scientific mission of the NIH and to the public health. A conference/scientific meeting is defined as a gathering, symposium, seminar, scientific meeting, workshop or any other organized, formal meeting where persons assemble to coordinate, exchange, and disseminate information or to explore or clarify a defined subject, problem, or area of knowledge. Each NIH Institute and Center (IC) has a scientific purview and different program goals and initiatives that evolve over time. Prior to preparing an application, it is critical that all applicants consult the appropriate IC representative listed in the R13/U13 Website (http://grants.nih.gov/grants/funding/r13/) to obtain current information about IC specific program priorities and policies. This action is of utmost importance because applications with marginal or no relevance to the participating Institutes will not be accepted for review or possible funding. In addition, applicants are encouraged to consult the Frequently Asked Questions Website for more detailed information about this program: http://grants.nih.gov/grants/funding/r13/index.htm The complete version of this PA is available at: http://grants.nih.gov/grants/guide/pa-files/PA-08-149.html
Midcareer Investigator Award in Patient-Oriented Research (K24)
The purpose of the Midcareer Investigator Award in Patient-Oriented Research is to provide support to mid-career health-professional doctorates or equivalent who are typically at the Associate Professor level or the equivalent (see Section III. Eligible Individuals) for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical faculty. The intent of this award is two-fold: 1) to enable mid-career clinician scientists to devote more time and to augment their capabilities in patient-oriented research; and 2) to enable mid-career clinical scientists to mentor new clinical investigators in the conduct of patient-oriented research. An award recipient who continues to have an independent peer-reviewed patient-oriented research program and continues to provide mentoring to new investigators can continue to contribute to the overall goals of the program after being promoted to Full professor. The complete version of this PA is available at: http://grants.nih.gov/grants/guide/pa-files/PA-08-151.html
New Technologies for Transient Molecular Complex Characterization (SBIR [R43/R44])
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new technologies, tools, and/or processes for the study of transient molecular complexes. Depending on the complex, such studies should have the potential for characterizing normal function or disease dysfunction and the effects of potential therapeutic interventions. Awards will be used to create new technologies, tools, and/or processes that will help to study transient molecular complexes that are an integral part of normal cell physiology or that play a role in disease processes. Structural (stoichiometry, localization, symmetry, and overall shape) and kinetic characterization of these short-lived complexes will provide insight leading to a better understanding of normal processes and a means to efficiently search for diagnostics or therapeutic interventions for disease conditions. The complete version of this PA is available at http://grants.nih.gov/grants/guide/pa-files/PA-08-110.html
New Technologies for Transient Molecular Complex Characterization (STTR [R41/R42])
This Funding Opportunity Announcement (FOA) solicits Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to develop new technologies, tools, and/or processes for the study of transient molecular complexes. Depending on the complex, such studies should have the potential for characterizing normal function or disease dysfunction and the effects of potential therapeutic interventions. Awards will be used to create new technologies, tools, and/or processes that will help to study transient molecular complexes that are an integral part of normal cell physiology or that play a role in disease processes. Structural (stoichiometry, localization, symmetry, and overall shape) and kinetic characterization of these short-lived complexes will provide insight leading to a better understanding of normal processes and a means to efficiently search for diagnostics or therapeutic interventions for disease conditions. The complete version of this PA is available at http://grants.nih.gov/grants/guide/pa-files/PA-08-111.html
In Utero Exposure to Bioactive Food Components and Mammary Cancer Risk (R01)
This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), the National Institute of Environmental Health Sciences (NIEHS), and the Office of Dietary Supplements (ODS), encourages innovative preclinical research applications that will enhance the understanding of the relationship between exposure(s) to bioactive food components and/or environmental chemicals in utero, hormonal and growth-factor response, gene expression or epigenetic changes, and subsequent mammary cancer risk in preclinical models. Although much evidence suggests that dietary components are linked to cancer prevention, the specific nutrients, sites of action, and role of exposure in utero remain elusive. Similarly, there are data suggesting a role for environmental agents such as mycotoxins, heterocyclic amines, and environmental chemicals with endocrine activity in the etiology of mammary cancer but the doses, windows of susceptibility, and mechanisms are unclear. This FOA encourages applications that apply new high-throughput genomic, epigenomic, proteomic, and metabolomic technologies to determine how dietary exposures in utero influence adult breast cancer susceptibility. The resulting information will help define effective maternal dietary intervention strategies for breast cancer prevention in her offspring. The complete version of this PA is available at: http://grants.nih.gov/grants/guide/pa-files/PA-08-141.html
In Utero Exposure to Bioactive Food Components and Mammary Cancer Risk (R21)
This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), the National Institute of Environmental Health Sciences (NIEHS), and the Office of Dietary Supplements (ODS), encourages innovative preclinical research applications that will enhance the understanding of the relationship between exposure(s) to bioactive food components and/or environmental chemicals in utero, hormonal and growth-factor response, gene expression or epigenetic changes, and subsequent mammary cancer risk in preclinical models. Although much evidence suggests that dietary components are linked to cancer prevention, the specific nutrients, sites of action, and role of exposure in utero remain elusive. Similarly, there are data suggesting a role for environmental agents such as mycotoxins, heterocyclic amines, and environmental chemicals with endocrine activity in the etiology of mammary cancer but the doses, windows of susceptibility, and mechanisms are unclear. This FOA encourages applications that apply new high-throughput genomic, epigenomic, proteomic, and metabolomic technologies to determine how dietary exposures in utero influence adult breast cancer susceptibility. The resulting information will help define effective maternal dietary intervention strategies for breast cancer prevention in her offspring. The complete version of this PA is available at: http://grants.nih.gov/grants/guide/pa-files/PA-08-141.html
Genetic Screens to Enhance Zebrafish Research (R01)
This FOA encourages investigator-initiated applications designed to exploit the power of the zebrafish as a ertebrate model for biomedical and behavioral research. Applications proposing to develop new genetic screens of high priority to the zebrafish community that will advance the detection and characterization of genes, pathways, and phenotypes of interest in development and aging, organ formation, neural processes, behavior, sensory processes, physiological processes, and disease processes are welcome. This effort stems from an NIH initiative developed by the Institutes and Centers of the Trans-NIH Zebrafish Coordinating Committee (TZCC) under the co-chairmanship of NICHD and NIDDK. The complete version of this PA is available at: http://grants.nih.gov/grants/guide/pa-files/PAR-08-138.html
Enhancing Zebrafish Research with Research Tools and Techniques (R01)
This FOA encourages investigator-initiated applications designed to exploit the power of the zebrafish as a vertebrate model for biomedical and behavioral research. Applications proposing to develop new research tools or techniques that are of high priority to the zebrafish community and that will advance the detection and characterization of genes, pathways, and phenotypes of interest in development and aging, organ formation, neural processes, behavior, sensory processing, physiological processes, and disease processes are welcome. This effort stems from an NIH initiative developed by the Institutes and Centers of the Trans-NIH Zebrafish Coordinating Committee (TZCC) under the co-chairmanship of NICHD and NIDDK. The complete version of this PA is available at: http://grants.nih.gov/grants/guide/pa-files/PAR-08-139.html
Probes and Instrumentation for Monitoring and Manipulating Nervous System Plasticity (R01)
This Funding Opportunity Announcement (FOA) is issued as an initiative of the NIH Blueprint for Neuroscience Research. The Neuroscience Blueprint is a collaborative framework through which 16 NIH Institutes, Centers and Offices jointly support neuroscience-related research, with the aim of accelerating discoveries and reducing the burden of nervous system disorders (for further information, see http://neuroscienceblueprint.nih.gov/). Applications are solicited for support of projects that will develop probes, instrumentation, and other tools for understanding, monitoring, and manipulating nervous system plasticity. This FOA will focus on the development of tools or techniques that will significantly advance the current state of the art in neuroplasticity research. Although applications will not be restricted to a particular type of technology, we are especially interested in applications that seek to harness the ability to assess and manipulate activity with exquisite subcellular resolution, and in cells specified by their circuit connectivity and/or transmitter phenotype. The complete version of this RFA is available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-09-030.html
The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R01)
The purposes of this FOA are to: 1) improve the measurement of racial /ethnic discrimination in health care delivery systems through improved instrumentation, data collection, and statistical/analytical techniques; 2) enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment, and outcomes among disadvantaged racial/ethnic minority groups; and 3) reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination in health care delivery systems in the United States (U.S.).
For the purposes of this FOA, health care delivery is defined as the provision or receipt of a broad range of health-related services including preventive, primary, ambulatory and in-patient, emergency, specialty and long-term care. Health care delivery systems are defined as insurance plans, hospitals, clinics, private physician offices, or public and community health facilities that provide or finance health care delivery. The complete version of the PA is available at http://grants.nih.gov/grants/guide/pa-files/PA-08-083.html
The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R21)
The goals of this funding opportunity are to: 1) improve the measurement of racial /ethnic discrimination in health care delivery systems through improved instrumentation, data collection, and statistical/analytical techniques; 2) enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment, and outcomes among disadvantaged racial/ethnic minority groups; and 3) reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination in health care delivery systems in the United States (U.S.).
For the purposes of this FOA, health care delivery is defined as the provision or receipt of a broad range of health-related services including preventive, primary, ambulatory and in-patient, emergency, specialty and long-term care. Health care delivery systems are defined as insurance plans, hospitals, clinics, private physician offices, or public and community health facilities that provide or finance health care delivery. The complete version of the PA is available at http://grants.nih.gov/grants/guide/pa-files/PA-08-084.html
The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R03)
The goals of this funding opportunity are to: 1) improve the measurement of racial /ethnic discrimination in health care delivery systems through improved instrumentation, data collection, and statistical/analytical techniques; 2) enhance understanding of the influence of racial/ethnic discrimination in health care delivery and its association with disparities in disease incidence, treatment, and outcomes among disadvantaged racial/ethnic minority groups; and 3) reduce the prevalence of racial/ethnic health disparities through the development of interventions to reduce the influence of racial/ethnic discrimination in health care delivery systems in the United States.
For the purposes of this FOA, health care delivery is defined as the provision or receipt of a broad range of health-related services including preventive, primary, ambulatory and in-patient, emergency, specialty and long-term care. Health care delivery systems are defined as insurance plans, hospitals, clinics, private physician offices, or public and community health facilities that provide or finance health care delivery. The complete version of the PA is available at http://grants.nih.gov/grants/guide/pa-files/PA-08-085.html
Pfizer Scholars Grants in Public Health - Junior Faculty Pursuing Community-Based, Public Health Practice Research
Pfizer Inc is proud to sponsor the Pfizer Scholars Grants in Public Health. These awards are meant to support the career development of junior faculty in public health. This educational grant is nationally competitive, and chosen by an independent Academic Advisory Board of recognized leaders in public health. More information is available at http://www.promisingminds.com/AwardDetails.asp x?AwardID=2081
Investigator Awards in Health Policy Research
The Investigator Awards in Health Policy Research program of the Robert Wood Johnson Foundation (RWJF) funds highly qualified individuals to undertake broad studies of the most challenging policy issues in health and health care facing America. Grants of up to $335,000 are awarded to investigators from a variety of disciplines. Successful proposals combine creative and conceptual thinking with innovative approaches to critical health problems and policy issues. The complete Call for Applications is available at http://www.investigatorawards.org/
Community Participation in Research (R01)
The National Institutes of Health (NIH) issues this Funding Opportunity Announcement (FOA) to solicit research project (R01) grant applications that propose intervention research on health promotion, disease prevention, and health disparities that communities and researchers jointly conduct.
Community-based participatory research (CBPR) is defined as scientific inquiry conducted in communities and in partnership with researchers. The process of scientific inquiry is such that community members, persons affected by the health condition, disability or issue under study, or other key stakeholders in the community's health have the opportunity to be full participants in each phase of the work (from conception – design – conduct – analysis –interpretation – conclusions – communication of results). CBPR is characterized by substantial community input in the development of the grant application (http://odoerdb2-1.od.nih.gov/oer/training/esaig/cbprsig_IG.htm).
For the purposes of this FOA, intervention research is quasi-experimental research projects that seek to influence preventive behaviors, treatment adherences, complementary behaviors, and related attitudes and beliefs. Natural experiments also may fall under the interventions rubric. Examples include, and are not limited to promotion of physical activity-friendly neighborhoods; tobacco, alcohol and drug abuse prevention among youth; a community-led action plan for cancer, hypertension and cardiovascular disease prevention and control in minority populations; establishing safer work practices among agricultural workers in rural areas; nutrition and reducing childhood obesity; HIV/AIDS and STD prevalence among young adults; promoting infant mental health; and reducing health disparities. The complete version of this PA is available at http://grants.nih.gov/grants/guide/pa-files/PA-08-074.html.
Community Participation Research Targeting the Medically Underserved (R01)
The National Institutes of Health (NIH) issues this Funding Opportunity Announcement (FOA) with a special review to solicit research project (R01) grant applications that propose research on health promotion, disease prevention, and health disparities that is jointly conducted by communities and researchers and targets medically underserved areas (MUAs) and medically underserved populations (MUPs) as defined by the Department of Health and Human Services (DHHS) Health Resources and Services Administration (HRSA).
Community-based participatory research (CBPR) is defined as scientific inquiry conducted in communities and in partnership with researchers. The process of scientific inquiry is such that community members, persons affected by the health condition, disability or issue under study, or other key stakeholders in the community's health have the opportunity to be full participants in each phase of the work (from conception – design – conduct – analysis – interpretation – conclusions – communication of results). CBPR is characterized by substantial community input in the development of the grant application (http://odoerdb2-1.od.nih.gov/oer/training/esaig/cbprsig_IG.htm). The complete version of this PAR is available at http://grants.nih.gov/grants/guide/pa-files/PAR-08-075.html
Community Participation Research Targeting the Medically Underserved (R21)
The National Institutes of Health (NIH) issues this Funding Opportunity Announcement (FOA) with a special review to solicit exploratory/developmental (R21) grant applications that propose research on health promotion, disease prevention, and health disparities that is jointly conducted by communities and researchers and targets medically underserved areas (MUAs) and medically underserved populations (MUPs) as defined by the Department of Health and Human Services (DHHS) Health Resources and Services Administration (HRSA).
Community-based participatory research (CBPR) is defined as scientific inquiry conducted in communities and in partnership with researchers. The process of scientific inquiry is such that community members, persons affected by the health condition, disability or issue under study, or other key stakeholders in the community's health have the opportunity to be full participants in each phase of the work (from conception – design – conduct – analysis – interpretation – conclusions – communication of results). CBPR is characterized by substantial community input in the development of the grant application (http://odoerdb2-1.od.nih.gov/oer/training/esaig/cbprsig_IG.htm). The complete version of this PAR is available at http://grants.nih.gov/grants/guide/pa-files/PAR-08-076.html
The Science and Ecology of Early Development (SEED) [R03]
SCOPE: The common characteristic of the small grant is provision of limited funding for a short period of time. Examples of the types of projects that ICs support with the R03 include the following:
-
Pilot or feasibility studies
-
Secondary analysis of existing data
-
Small, self-contained research projects
This Funding Opportunity Announcement (FOA), jointly issued by the Child Development and Behavior Branch (CDBB) and the Demographic and Behavioral Sciences Branch (DBSB) of the National Institute of Child Health and Human Development (NICHD), Division of Epidemiology, Services and Prevention Research of the National Institute on Drug Abuse (NIDA), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), invites research grant applications that seek to develop or contribute to a comprehensive program of research focused on the mechanisms through which social, economic, cultural, familial and community-level factors, and their interactions, impact the early cognitive, neurobiological, socio-emotional, and physical development of children. Understanding the influence of these mechanisms and the pathways by which they operate is especially important for understanding the impact of available services and the public policies which govern them on the development of children at whom (or at whose families) these policies are often specifically targeted, notably children living in poverty or near the federal poverty line. Arenas of particular relevance include childcare, early childhood education, welfare reform, tax, social services, and work-family policies, as all of these shape the life experiences of children in poverty. Thus, the goal is to generate solid scientific information that would bear directly on these arenas and thus inform policies and the design of service delivery programs that impact child development, whether or not child development is the explicit focus of those policies and services. This FOA extends the seven-year Science and Ecology of Early Development (SEED) initiative and is the outgrowth of an interagency collaborative effort from 2000 through 2004 among the following agencies: 1) U.S. Department of Health and Human Services [NICHD, National Institute of Mental Health (NIMH), NIDA, Administration for Children and Families (ACF), Office of the Assistant Secretary for Planning and Evaluation (ASPE), and the Centers for Disease Control and Prevention (CDC)], and 2) the Department of Education (National Center for Education Statistics, National Center for Education Research, and the National Center for Special Education Research in the Institute of Education Sciences). These agencies have pursued other avenues of supporting research on this topic. NICHD and NIDA have continued to collaborate on this Funding Opportunity Announcement. Details of that earlier initiative can be found at http://grants.nih.gov/grants/guide/pa-files/PA-06-345.html and http://grants.nih.gov/grants/guide/pa-files/PA-07-149.html. The complete version of this PA is available at http://grants.nih.gov/grants/guide/pa-files/PA-08-068.html.
Nanoscience and Nanotechnology in Biology and Medicine (R01)
Nanoscience and nanotechnology refer to the understanding and control of matter at the atomic, molecular or macromolecular levels, at the length scale of approximately 1–100 nanometers. The purpose of this funding opportunity is to stimulate nanoscience and nanotechnology research approaches that have the potential to make valuable contributions to biology and medicine. Nanoscience and nanotechnology can bring fundamental changes to the study and understanding of biological processes in health and disease, as well as enable novel diagnostics and interventions for treating disease. Thus, advances based on nanotechnology and nanoscience could result in a new era in healthcare. The complete version of this PA is available at http://grants.nih.gov/grants/guide/pa-files/PA-08-052.html.
Predictive Multiscale Models of the Physiome in Health and Disease (R01)
The goal of this solicitation is to move the field of biomedical computational modeling forward through the development of more realistic and predictive models of health and disease. NIH recognizes the need for sophisticated, predictive, computational models of development and disease that encompass multiple biological scales. These models may be designed to uncover biological mechanisms or to make predictions about clinical outcome and may draw on a variety of data sources including relevant clinical data. Ultimately the models and the information derived from their use will enable biomedical and behavioral researchers and clinicians to better understand, prevent, diagnose and treat the diseases or aberrations in normal development. Specifically this FOA seeks the development of biomedical models that are 1) multiscale, 2) predictive of health and disease states, and 3) that must include models at higher scales of the physiome. The complete version of this PAR is available at: http://grants.nih.gov/grants/guide/pa-files/PAR-08-023.html
NIAID Science Education Awards (R25)
This funding opportunity announcement (FOA) solicits applications from applicant organizations that propose creative and innovative research education programs that will 1) increase the public's understanding of biomedical research, or 2) encourage K-12 students to enter areas in biomedical science in the mission area(s) of the National Institute of Allergy and Infectious Diseases (NIAID). The NIH Research Education (R25) grant mechanism is a flexible and specialized mechanism designed to foster the development of biomedical, behavioral, and clinical researchers through creative and innovative research education programs. The complete version of this PAR is available at http://grants.nih.gov/grants/guide/pa-files/PAR-08-003.html.
